Pasar al contenido principal

Neuroimaging and mental health: from vulnerability factors to the development of novel prevention and treatment strategies

RYC2021-031228-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT JAUME I DE CASTELLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study

  • Si, Shuqing
  • Tordesillas-Gutiérrez, Diana
S. Si et al., [Introduction] Regional gray matter (GM) alterations have been reported in early-onset psychosis (EOP, onset before age 18), but previous studies have yielded conflicting results, likely due to small sample sizes and the different brain regions examined. In this study, we conducted a whole brain voxel-based morphometry (VBM) analysis in a large sample of individuals with EOP, using the newly developed ENIGMA-VBM tool., [Methods] 15 independent cohorts from the ENIGMA-EOP working group participated in the study. The overall sample comprised T1-weighted MRI data from 482 individuals with EOP and 469 healthy controls. Each site performed the VBM analysis locally using the standardized ENIGMA-VBM tool. Statistical parametric T-maps were generated from each cohort and meta-analyzed to reveal voxel-wise differences between EOP and healthy controls as well as the individual-based association between GM volume and age of onset, chlorpromazine (CPZ) equivalent dose, and other clinical variables., [Results] Compared with healthy controls, individuals with EOP showed widespread lower GM volume encompassing most of the cortex, with the most marked effect in the left median cingulate (Hedges’ g = 0.55, p = 0.001 corrected), as well as small clusters of lower white matter (WM), whereas no regional GM or WM volumes were higher in EOP. Lower GM volume in the cerebellum, thalamus and left inferior parietal gyrus was associated with older age of onset. Deficits in GM in the left inferior frontal gyrus, right insula, right precentral gyrus and right superior frontal gyrus were also associated with higher CPZ equivalent doses., [Conclusion] EOP is associated with widespread reductions in cortical GM volume, while WM is affected to a smaller extent. GM volume alterations are associated with age of onset and CPZ equivalent dose but these effects are small compared to case-control differences. Mapping anatomical abnormalities in EOP may lead to a better understanding of the role of psychosis in brain development during childhood and adolescence., MB is supported by a NHMRC Senior Principal Research Fellowship and Leadership 3 Investigator grant (1156072 and 2017131). The Hospital Clinic Barcelona - IDIBAPS cohort has been supported by the following funding agencies: the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, (PI18/00976, PI20/00654, PI02100330), Ajut a la Recerca Pons Bartran, the Alicia Koplowitz Foundation, Brain and Behavior Research Foundation (NARSAD Young Investigator Award 2017) and Strategic Research and Innovation Plan in Health (PERIS), Department of Health, Government of Catalonia. CA, CDC and JJ are supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, ERDF Funds from the European Commission, “A way of making Europe”, financed by the European Union - NextGenerationEU (PMP21/00051), PI19/01024, PI20/00721, JR19/00024. CIBERSAM, Madrid Regional Government (S2022/BMD-7216 (AGES 3-CM)), European Union Structural Funds, European Union Seventh Framework Program, European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 (Grant agreement No.101034377), Project AIMS-2-TRIALS (Grant agreement No 777394), Horizon Europe, the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01MH124639-01 (Project ProNET) and Award Number 5P50MH115846-03 (project FEP-CAUSAL), Fundación Familia Alonso, and Fundación Alicia Koplowitz. YTOP cohort is supported by The Research Council of Norway (223273, 213700, 250358, 288083, 334326); South-Eastern Norway Regional Health Authority (2017112); KG Jebsen Stiftelsen (SKGJ-MED-008). SCAPS cohort is supported by The Swedish Research Council (521-2014-3487, 2017-00949); FORMAS (259-2012-31). RUND cohort is supported by South-Eastern Norway Regional Health Authority (#2004-259, # 2006-186). MPP is supported by the grant RYC2021‐031228‐I funded by MCIN/AEI/10.13039/50110 0011033 and by the “European Union NextGenerationEU/ PRTR”. PM’s work has been partially funded by National funds, through the Foundation for Science and Technology (FCT) - project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000039, supported by Norte Portugal Regional Operational Program (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). The study was partially funded by the Italian Ministry of Health, Ricerca Corrente 23. SIT, NJ, PMT were supported in part by NIH grants: R01AG059874, R01MH134004, R01MH116147, R01MH121246, and P41EB015922. JJC is supported by a National Health and Medical Research Council (NHMRC) Emerging Leadership EL1 Fellowship (2008197). IBH is supported by a National Health and Medical Research Council (NHMRC) Leadership 3 Fellowship (2016346)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder

  • Cardoso Saraiva, Leonardo
  • Sato, Joao R.
  • Sebenius, Isaac
  • Dzinalija, Nadza
  • Río-Torné, Carla del
  • Godinho, Fábio
  • Lopes, Antonio C.
  • Fernandez, Thomas V.
  • Lima, Monicke O.
  • Ramos, Vanessa R.
  • Iglesio, Ricardo
  • Abe, Yoshinari
  • Alonos, Pino
  • Ameis, Stephanie H.
  • Anticevic, Alan
  • Araújo, Ana
  • Arnold, Paul D.
  • Balachander, Srinivas
  • Banaj, Nerisa
  • Batistuzzo, Marcelo C.
  • Benedetti, Francesco
  • Bollettini, Irene
  • Bravi, Beatrice
  • Brennan, Brian
  • Buitelaar, Jan
  • Castelo-Branco, Miguel
  • Choi, Sunah
  • Costa, Ana D.
  • Dellaspezia, Sara
  • Denys, Damiaan
  • Duarte, Isabel C.
  • Echevarria, Marco A. N.
  • Eng, Goi Khia
  • Fernandes, Afonso
  • Feusner, Jamie D.
  • Figee, Martijn
  • Fitzsimmons, Sophie M. D. D.
  • Fontenelle, Leonardo F.
  • Grazioplene, Rachael
  • Ha, Minji
  • Hinojosa, Alejandro
  • Hoexter, Marcelo Q.
  • Huijser, Chaim
  • Hu, Hao
  • James, Anthony
  • Kim, Minah
  • Kwon, Jun Soo
  • Lázaro, Luisa
  • Lochner, Christine
  • Machado-Sousa, Mafalda
  • Van Marle, Hein
  • Martínez-Zalacaín, Ignacio
  • Mataix-Cols, David
  • Menchón, José M.
  • Minuzzi, Luciano
  • Morgado, Pedro
  • Muñoz-Moreno, Emma
  • Nakao, Tomohiro
  • Narayanaswamy, Janardhanan C.
  • Nurmi, Erika L.
  • O'Neill, Joseph
  • Park, Inkyung
  • Philips, Mary L.
  • Piacentini, John C.
  • Pico-Pérez, María
  • Piras, Fabrizio
  • Piras, Federica
  • Postma, Tjardo S.
  • Li, Chiang-shan R.
  • Reddy, Janardhan Y. C.
  • Van Rooj, Daan
  • Sakai, Yuki
  • Andrade, Juliana B.
  • Scheffler, Freda
  • Shivakumar, Venkataram
  • Soreni, Noam
  • Stern, Emily R.
  • Van der Straten, Anouk
  • Thomopoulos, Sophia I.
  • Tomiyama, Hirofumi
  • Tovar-Moll, Fernanda
  • Vecchio, Daniela
  • Veltman, Dick J.
  • Venkatasubramanian, Ganesan
  • Vriend, Chris
  • Wang, Zhen
  • Van der Werf, Ysbrand
  • Van Wingen, Guido
  • Zhao, Qing
  • ENIGMA-OCD Working Group
  • Charney, Alexander W.
  • Cho, Youngsun T.
  • Shavitt, Roseli G.
  • Pushkarskaya, Helen
  • Soriano-Mas, Carles
  • Romero-García, Rafael
  • Thompson, Paul M.
  • Stein, Dan J.
  • Van den Heuvel, Odile A.
  • Winkler, Anderson M.
  • Miguel Filho, Euripides C.
  • Pittenger, Christopher
  • Cappi, Carolina
Studies of brain morphology in mental illness often focus on a few neuroimaging phenotypes. Here we present a comprehensive morphological characterization in obsessive-compulsive disorder (OCD) in a large sample (2255 OCD, 2264 controls) using nine cortical and four subcortical phenotypes, including several not previously examined in OCD, among them a subcortical structural similarity network phenotype developed here. Spatially distinct regional alterations emerged across structural phenotypes: cortical curvature alterations in default mode and frontoparietal networks, increased structural similarity network node degree in sensorimotor regions, widespread volume reductions associated with medication use, and localized subcortical shape alterations. In brain-behavior predictive models, curvature phenotypes showed the strongest associations with clinical features. Cortical alterations, especially in structural similarity networks, were associated with specific gene expression patterns, implicating dysregulation of excitatory neurons. RNA-sequencing data from tissue collected during functional neurosurgery revealed that genes downregulated in the dorsolateral prefrontal cortex in OCD contributed to the gene expression patterns linked to cortical alterations. Previously reported differentially expressed genes from postmortem brain studies of OCD also contributed. These findings support the importance of a comprehensive approach to characterizing brain morphology and suggest that cortical curvature and structural similarity alterations reflect key pathophysiological processes in OCD., L.C.S. was supported by the International OCD Foundation 2025 Jenike Young Investigator Award, NIH grant R01MH130609 (to C.P.), and Sao Paulo Research Foundation scholarships 2020/12484-6 and 2022/10207-0. J.R.S. was supported by Sao Paulo Research Foundation grants 2023/18337-3 and 2023/02538-0. N.D. was supported by the International OCD Foundation Innovator Award of 2021. Y.A. was supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI) grant 23K14825. P.A. was supported by PI22/00752 from Instituto de Salud Carlos III and MAR22005 from Fundació La Marató. S.H.A. was supported by the Canadian Institutes of Health Research, the Canada Research Chairs Program, the University of Toronto, and the CAMH Foundation. A.A. was supported by the Portuguese Foundation for Science and Technology (grant 2020.08114.BD). P.D.A. was supported by the Ontario Brain Institute, the Hotchkiss Brain Institute, the Alberta Children’s Hospital Foundation, and the Alberta Innovates Translational Health Chair in Child and Youth Mental Health, and holds a patent for SLCIAI Marker for Anxiety Disorder granted May 6, 2008. S.B. was supported by a Río Hortega grant (CM21/00278) from the Carlos III Health Institute (co-funded by the European Social Fund, Investing in Your Future). J.B. was supported by the European Union 7th Framework Program TACTICS consortium (grant 278948). J.C. was supported by the Portuguese Foundation for Science and Technology (grants DL 57/2016/CP1370/CT0066 and CEECINST/00117/2021/CP2784/CT0001). M.C.B. was supported by the Portuguese Foundation for Science and Technology (grant UIDP/4950/2020). A.D.C. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2022.09472.BD). I.C.D. was supported by the Portuguese Foundation for Science and Technology (grants UIDP/4950/2020 and 2022.04701.PTDC). G.K.E. was supported by NIH grants R21/R33MH107589 and R01MH111794 (awarded to E.R.S.). A.F. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2022.12528.BD). J.D.F. was supported by NIMH grant R01MH085900. L.F.F. was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (#302526/2018-8), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (#CNE E-26/200.950/2021), and the D’Or Institute of Research and Education (IDOR). J.I. was supported by NIMH grant R01MH131022. M.K. was supported by the Brain Science Convergence Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science & ICT (grant RS-2023-00266120). L.L. was supported by the Marató Foundation grants 01/2010 and 091710. C.L. was supported by the National Research Foundation of South Africa. M.M.S. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2020.07946.BD). D.M.C. was supported by the International OCD Foundation Breakthrough Grant, the Swedish Brain Foundation (Hjärnfonden; FO2017-0154 and FO2020-0139), and the Region Stockholm ALF Medicine funding program (20200137). P.M. was supported by Portuguese Foundation for Science and Technology projects UIDB/50026/2020, UIDP/50026/2020, and LA/P/0050/2020, and by project NORTE-01-0145-FEDER-000039 through the European Regional Development Fund. T.N. was supported by JSPS KAKENHI grant JP21K07547. J.C.N. was supported by the Department of Science and Technology (DST INSPIRE faculty grant IFA12-LSBM-26) and the Department of Biotechnology (BT/06/IYBA/2012). J.O. was supported by NIMH grants R01MH085900 and R01MH081864. J.C.P. was supported by NIMH grant R01MH081864. M.P.P. was supported by grant RYC2021-031228-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. F.P. was supported by the Italian Ministry of Health (Ricerca Corrente 2024). Y.C.J.R. was supported by the Department of Science and Technology (SR/S0/HS/0016/2011) and the Department of Biotechnology (BT/PR13334/Med/30/259/2009). Y.S. was supported by AMED grants JP23wm0625001 and JP24wm0625204. J.B.S.A. was supported by a postdoctoral scholarship from Fundação Maria-Emília (Brazil). E.R.S. was supported by NIH grants R21/R33MH107589 and R01MH111794. S.I.T. was supported by NIH grant R01MH138569 (MEGA-OCD). H.T. was supported by JSPS KAKENHI grant JP22K15766. F.T.M. was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, the D’Or Institute for Research and Education, and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro. G.V. was supported by the Wellcome-DBT India Alliance grant 500236/Z/11/Z. C.V. was supported by the International OCD Foundation Innovator Award of 2021. Z.W. was supported by the Key Program of the National Natural Science Foundation of China (82230045). A.W. was supported by JSPS KAKENHI grant 21K15749. G.V.W. was supported by ZonMw grants 165.610.002 and 016.156.318. Y.T.C. was supported by Neumora Therapeutics (formerly BlackThorn Therapeutics). C.S.M. was supported by Instituto de Salud Carlos III (PI16/00889, PI19/01171), Departament de Salut (PERIS SLT006/17/249), Fundació Marató de TV3 (202201-31), Agència de Gestió d’Ajuts Universitaris i de Recerca (2021SGR01017), and Ministerio de Ciencia e Innovación (PID2022−139081OB-C21). R.R.G. was supported by the EMERGIA Junta de Andalucía program (EMERGIA20_00139), Plan de Consolidación (CNS2023-143647), and Plan de Generación de Conocimiento (PID2021-122853OA-I00) of the Agencia Estatal de Investigación. P.M.T. was supported by NIH grant R01MH138569 (MEGA-OCD). D.J.S. was supported by the South African Medical Research Council (SAMRC). O.A.H. was supported by the International OCD Foundation Innovator Award of 2021 and by NIMH grant R01MH138569-01 (MEGA-OCD). C.P. was supported by NIH grant R01MH116038. C.C. was supported by NIH grant 1K99MH128540-01., Peer reviewed